Skip to content

Biology of Thymic Tumors

Biological Analysis of a Series of Thymoma and Thymic Carcinoma: Genetic Aberrations and Potential Therapy Targets.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00965627
Enrollment
134
Registered
2009-08-25
Start date
2008-06-30
Completion date
2009-08-31
Last updated
2009-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymoma

Brief summary

This is a retrospective analysis of biological characteristics of thymoma and thymic carcinoma patients.

Detailed description

The aim of the present study is to investigated the genetic alterations in tumor samples of a series of all WHO-defined subtypes of thymoma patients using high resolution microarray- comparative genomic hybridization (CGH) followed by hierarchical cluster analyses of the data to identify specific patterns of genetic aberrations and genes associated with each subtype. Moreover, tumor samples will be also investigated for some specific potential therapy targets by immunoistichemistry, mutation analysis, and fluorescence in situ hybridization (FISH) analysis. All these biological data will be correlated with clinical patients characteristics and survival data.

Interventions

None listed

Sponsors

Istituto Clinico Humanitas
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Availability of tumor tissue and patients with thymoma and thymic carcinoma

Exclusion criteria

* NON Availability of tumor tissue and patients with thymoma and thymic carcinoma

Design outcomes

Primary

MeasureTime frame
Primary objective: to evaluate the presence of genetic alterations and specific potential therapy targets.one year

Secondary

MeasureTime frame
Secondary objective: to correlate the biological characteristics with clinical characteristics and survival data of patients.one year

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026